Last updated at 30 Jun 2025 09:33 AM
Director
DIN: 09679610
Harsh Janak Dharamshi is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at ENCORE BIOMEDICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09679610.Harsh Janak Dharamshi has previously been associated with 1 company in roles such as Director.Harsh Janak Dharamshi is currently involved in 2 different roles. Their most recent position is with CELLCARE DIAGNOSTIC LLP as a Designated Partner. The first company Harsh Janak Dharamshi was appointed to was ENCORE BIOMEDICALS PRIVATE LIMITED. Harsh Janak Dharamshi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Harsh Janak Dharamshi is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at ENCORE BIOMEDICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09679610.Harsh Janak Dharamshi has previously been associated with 1 company in roles such as Director.Harsh Janak Dharamshi is currently involved in 2 different roles. Their most recent position is with CELLCARE DIAGNOSTIC LLP as a Designated Partner. The first company Harsh Janak Dharamshi was appointed to was ENCORE BIOMEDICALS PRIVATE LIMITED. Harsh Janak Dharamshi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
8 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ENCORE BIOMEDICALS PRIVATE LIMITED | Individual Promoter | 20-Jul-2022 |